DAFNA Capital Management’s Cardiovascular Systems, Inc. CSII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-286,988
Closed -$5.7M 80
2023
Q1
$5.7M Hold
286,988
1.71% 17
2022
Q4
$3.91M Hold
286,988
1.1% 28
2022
Q3
$3.98M Hold
286,988
1.07% 30
2022
Q2
$4.12M Hold
286,988
1.12% 28
2022
Q1
$6.49M Hold
286,988
1.69% 15
2021
Q4
$5.39M Buy
286,988
+93,247
+48% +$2.49M 1.36% 20
2021
Q3
$6.36M Buy
193,741
+44,041
+29% +$1.64M 1.69% 15
2021
Q2
$6.38M Hold
149,700
1.34% 21
2021
Q1
$5.74M Sell
149,700
-1,500
-1% -$63.8K 1.36% 20
2020
Q4
$6.62M Hold
151,200
1.97% 12
2020
Q3
$5.95M Hold
151,200
1.93% 12
2020
Q2
$4.77M Buy
151,200
+100,000
+195% +$3.74M 1.38% 25
2020
Q1
$1.8M Buy
51,200
+5,000
+11% +$211K 0.75% 34
2019
Q4
$2.25M Hold
46,200
0.77% 30
2019
Q3
$2.19M Sell
46,200
-5,000
-10% -$235K 0.83% 32
2019
Q2
$2.2M Sell
51,200
-5,000
-9% -$194K 0.83% 33
2019
Q1
$2.17M Sell
56,200
-10,000
-15% -$339K 0.94% 31
2018
Q4
$1.89M Buy
66,200
+10,000
+18% +$318K 0.94% 31
2018
Q3
$2.2M Sell
56,200
-3,000
-5% -$111K 0.9% 37
2018
Q2
$1.92M Buy
+59,200
New +$1.63M 0.9% 32

Other funds holding CSII

DAFNA Capital Management's CSII Position: Q2 2023 in Review

DAFNA Capital Management sold out of Cardiovascular Systems, Inc. (CSII) in Q2 2023, closing a stake of 286,988 shares — an estimated $5.7M sold.

DAFNA Capital Management first reported a position in CSII in Q2 2018 and held it in 20 quarters. The position peaked at $6.62M in Q4 2020. 2 funds tracked by Wall St. Rank hold CSII as of Q2 2023.

  • DAFNA Capital Management reported no remaining Cardiovascular Systems, Inc. position as of Q2 2023 after selling out during the quarter.
  • DAFNA Capital Management sold 286,988 Cardiovascular Systems, Inc. shares in Q2 2023, an estimated $5.7M.
  • DAFNA Capital Management first reported a position in Cardiovascular Systems, Inc. in Q2 2018 and held it in 20 quarters.
  • DAFNA Capital Management's Cardiovascular Systems, Inc. position peaked at $6.62M in Q4 2020.
  • 2 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q2 2023.

Based on DAFNA Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.